+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Consumer Health in Belgium

  • PDF Icon

    Report

  • 119 Pages
  • September 2023
  • Region: Belgium
  • Euromonitor International
  • ID: 2626759
Consumer health in Belgium continues to see steady growth in current value terms in 2023, albeit at a slightly slower pace than in the previous year. Among the most dynamic categories are analgesics, sleep aids (driven by high stress levels among the population), motion sickness remedies (due to the recovery of travel and tourism), sports nutrition and cough, cold and allergy (hay fever) remedies.

The analyst's Consumer Health in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage:
Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage:
Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

CONSUMER HEALTH IN BELGIUM
EXECUTIVE SUMMARY
  • Consumer health in 2023: The big picture
  • 2023 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
  • Table 2 Life Expectancy at Birth 2018-2023
MARKET DATA
  • Table 3 Sales of Consumer Health by Category: Value 2018-2023
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2018-2023
  • Table 5 NBO Company Shares of Consumer Health: % Value 2019-2023
  • Table 6 LBN Brand Shares of Consumer Health: % Value 2020-2023
  • Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
  • Table 8 Distribution of Consumer Health by Format: % Value 2018-2023
  • Table 9 Distribution of Consumer Health by Format and Category: % Value 2023
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2023-2028
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources
ANALGESICS IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • More stable environment ensures stable growth for analgesics
  • Topical analgesics/anaesthetic fail to take off despite more favourable conditions
  • Dafalgan thriving while generics forge ahead with strong value proposition
PROSPECTS AND OPPORTUNITIES
  • Sales threatened by ongoing risks of product shortages coupled with rising inflation and increasing price sensitivity
  • Concerns over specific ingredients and indirect competition pose further threats to growth
  • Category maturity expected to lead to a drop in sales
CATEGORY DATA
  • Table 12 Sales of Analgesics by Category: Value 2018-2023
  • Table 13 Sales of Analgesics by Category: % Value Growth 2018-2023
  • Table 14 NBO Company Shares of Analgesics: % Value 2019-2023
  • Table 15 LBN Brand Shares of Analgesics: % Value 2020-2023
  • Table 16 Forecast Sales of Analgesics by Category: Value 2023-2028
  • Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Sales continue to flourish but growth stabilises after a vintage year for cough, cold and allergy (hay fever) remedies
  • Rise in seasonal allergies favours sales of antihistamines/allergy remedies (systemic)
  • Competition heats up despite supply shortages
PROSPECTS AND OPPORTUNITIES
  • Growing awareness about the possible dangers of some combination cough, cold and allergy (hay fever) remedies and pseudoephedrine
  • Seasonal pathologies could be less strong but last longer
  • Category maturity could limit growth opportunities
CATEGORY DATA
  • Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
  • Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
  • Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2023
  • Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2023
  • Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2023-2028
  • Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2023-2028
DIGESTIVE REMEDIES IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Digestive remedies seeing positive growth as life in Belgium returns to normal
  • Diarrhoeal remedies benefits from lack of COVID-19 controls
  • Imodium and Movicol succeed by offering different but effective forms of relief
PROSPECTS AND OPPORTUNITIES
  • IBS treatments and proton pump inhibitors struggling to find an audience
  • Motion sickness remedies one of the few bright spots in digestive remedies
  • Digestive remedies facing several significant challenges
CATEGORY DATA
  • Table 24 Sales of Digestive Remedies by Category: Value 2018-2023
  • Table 25 Sales of Digestive Remedies by Category: % Value Growth 2018-2023
  • Table 26 NBO Company Shares of Digestive Remedies: % Value 2019-2023
  • Table 27 LBN Brand Shares of Digestive Remedies: % Value 2020-2023
  • Table 28 Forecast Sales of Digestive Remedies by Category: Value 2023-2028
  • Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2023-2028
DERMATOLOGICALS IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Drop in foot traffic at pharmacies a challenge for sales of dermatologicals
  • A mix of price increase and post-covid effect
  • Janssen-Cilag NV retains the lead but faces increasing competition as demand for dermatologicals returns
PROSPECTS AND OPPORTUNITIES
  • The normalisation of consumer lifestyles and retailing are good signs for sales of dermatologicals
  • Competition from Rx and beauty and personal care products a potential obstacle to growth
  • Economic pressure could push consumers to seek out the best value bring an end to some trends
CATEGORY DATA
  • Table 30 Sales of Dermatologicals by Category: Value 2018-2023
  • Table 31 Sales of Dermatologicals by Category: % Value Growth 2018-2023
  • Table 32 NBO Company Shares of Dermatologicals: % Value 2019-2023
  • Table 33 LBN Brand Shares of Dermatologicals: % Value 2020-2023
  • Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2020-2023
  • Table 35 Forecast Sales of Dermatologicals by Category: Value 2023-2028
  • Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2023-2028
NRT SMOKING CESSATION AIDS IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Ban on nicotine pouches in 2023 and the withdrawal of Champix big positives for sales of NRT smoking cessation aids
  • Increase in tobacco prices supports growth
  • Despite limited innovation, Nicorette secures the lion’s share
PROSPECTS AND OPPORTUNITIES
  • New taxes on tobacco and subsequent prices increases could boost sales, but access to illicit tobacco remains a threat
  • E-vapour products will remain a serious competitor but new legislation could swing things in favour of NRT smoking cessation aids
  • Potential deregulation and better reimbursement could influence demand
  • CATEGORY INDICATORS
  • Table 37 Number of Smokers by Gender 2018-2023
CATEGORY DATA
  • Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
  • Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023
  • Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2019-2023
  • Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2020-2023
  • Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2023-2028
  • Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2023-2028
SLEEP AIDS IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Conditions remain favourable for sales of sleep aids despite the end of the pandemic
  • Competition intensifies as consumers go in search of the most effective products
  • More gummies and advertising support
PROSPECTS AND OPPORTUNITIES
  • Sleep aids likely to remain popular but could suffer from increasing maturity
  • Ingredients remain a key selling point for sleep aids but gummies could lose their way due to high prices
  • Possible new competition from other consumer health products and the resilience of Rx medicines
CATEGORY DATA
  • Table 44 Sales of Sleep Aids: Value 2018-2023
  • Table 45 Sales of Sleep Aids: % Value Growth 2018-2023
  • Table 46 NBO Company Shares of Sleep Aids: % Value 2019-2023
  • Table 47 LBN Brand Shares of Sleep Aids: % Value 2020-2023
  • Table 48 Forecast Sales of Sleep Aids: Value 2023-2028
  • Table 49 Forecast Sales of Sleep Aids: % Value Growth 2023-2028
EYE CARE IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • High pollen count and flexible work arrangements help to boost demand for eye care in 2023
  • Long waiting lists for ophthalmologists an obstacle to stronger growth
  • Théa Pharma retains its lead in a fiercely competitive landscape
PROSPECTS AND OPPORTUNITIES
  • Too low level of self-medication for OTC sales of eye care
  • Ophthalmologists likely to remain a key B2B target for sales of eye care
  • Market saturation and competition from Rx products could hinder the growth of eye care
CATEGORY DATA
  • Table 50 Sales of Eye Care by Category: Value 2018-2023
  • Table 51 Sales of Eye Care by Category: % Value Growth 2018-2023
  • Table 52 NBO Company Shares of Eye Care: % Value 2019-2023
  • Table 53 LBN Brand Shares of Eye Care: % Value 2020-2023
  • Table 54 Forecast Sales of Eye Care by Category: Value 2023-2028
  • Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2023-2028
WOUND CARE IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Sales benefit from more favourable conditions in 2023 although inflation impedes stronger volume gains
  • Pharmacies struggling to compete with the lower prices offered by grocery retailers
  • Beiersdorf’s Hansaplast retains its healthy lead but faces growing competition from generics and private label
PROSPECTS AND OPPORTUNITIES
  • Economic pressures leave limited room for growth in products with added-value
  • Wound care unlikely to see full recovery but warmer weather could bring some positive results
  • Pure online players and private label have excellent opportunities for growth and development
CATEGORY DATA
  • Table 56 Sales of Wound Care by Category: Value 2018-2023
  • Table 57 Sales of Wound Care by Category: % Value Growth 2018-2023
  • Table 58 NBO Company Shares of Wound Care: % Value 2019-2023
  • Table 59 LBN Brand Shares of Wound Care: % Value 2020-2023
  • Table 60 Forecast Sales of Wound Care by Category: Value 2023-2028
  • Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2023-2028
VITAMINS IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Sales of vitamins normalise after the dynamism seen during the pandemic
  • Vitamin B the one positive while multivitamins become too expensive
  • Most players bear the brunt of the slowdown in demand with Meda Pharma one of the few exceptions
PROSPECTS AND OPPORTUNITIES
  • Mixed outlook for vitamins as life returns to relative normality
  • Uncertain outlook for multivitamins
  • Research results could have positive and negative implications for vitamins
CATEGORY DATA
  • Table 62 Sales of Vitamins by Category: Value 2018-2023
  • Table 63 Sales of Vitamins by Category: % Value Growth 2018-2023
  • Table 64 Sales of Multivitamins by Positioning: % Value 2018-2023
  • Table 65 NBO Company Shares of Vitamins: % Value 2019-2023
  • Table 66 LBN Brand Shares of Vitamins: % Value 2020-2023
  • Table 67 Forecast Sales of Vitamins by Category: Value 2023-2028
  • Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2023-2028
DIETARY SUPPLEMENTS IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Sales of dietary supplements threatened by economic downturn
  • Immunity no longer in focus as Belgians shift their focus to beauty and wellbeing
  • Small and medium-sized local players fare better than larger ones
PROSPECTS AND OPPORTUNITIES
  • Belgians expected to turn their attention to wellbeing and beauty claims
  • Small and medium-sized local players expected to pose a stronger challenge to the larger manufacturers
  • Dietary supplements facing numerous challenges despite increasingly positive perceptions around the use of these products
CATEGORY DATA
  • Table 69 Sales of Dietary Supplements by Category: Value 2018-2023
  • Table 70 Sales of Dietary Supplements by Category: % Value Growth 2018-2023
  • Table 71 Sales of Dietary Supplements by Positioning: % Value 2018-2023
  • Table 72 NBO Company Shares of Dietary Supplements: % Value 2019-2023
  • Table 73 LBN Brand Shares of Dietary Supplements: % Value 2020-2023
  • Table 74 Forecast Sales of Dietary Supplements by Category: Value 2023-2028
  • Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2023-2028
WEIGHT MANAGEMENT AND WELLBEING IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • New innovations help drive value growth
2023: Another tough year for weight management and wellbeing
  • Competition continues to grow as players introduce new innovations
PROSPECTS AND OPPORTUNITIES
  • Focus on healthy home-cooked meals could threaten sales of weight management and wellbeing
  • Ongoing progression expected for slimming teas and supplement nutrition
  • Bleak prospects overall for sales of weight management & wellbeing
CATEGORY DATA
  • Table 76 Sales of Weight Management and Wellbeing by Category: Value 2018-2023
  • Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2018-2023
  • Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2019-2023
  • Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2020-2023
  • Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2023-2028
  • Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2023-2028
SPORTS NUTRITION IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Reopening of gyms closely tied to the growth and recovery of sports nutrition
  • Switch to home workout routines disrupts the recovery of vending
  • Decathlon thriving as competition heats up across sports nutrition
PROSPECTS AND OPPORTUNITIES
  • Deeper penetration anticipated for sports nutrition despite but a possible slowdown in the opening of new gyms
  • Increasing number of runners, hikers and cyclists should boost sales of sports non-protein products
  • Vegan recipes likely to see increasing demand while online sales are set to grow
CATEGORY DATA
  • Table 82 Sales of Sports Nutrition by Category: Value 2018-2023
  • Table 83 Sales of Sports Nutrition by Category: % Value Growth 2018-2023
  • Table 84 NBO Company Shares of Sports Nutrition: % Value 2019-2023
  • Table 85 LBN Brand Shares of Sports Nutrition: % Value 2020-2023
  • Table 86 Forecast Sales of Sports Nutrition by Category: Value 2023-2028
  • Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2023-2028
HERBAL/TRADITIONAL PRODUCTS IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Herbal/traditional products thriving in 2023 as cases of cold and flu rise
  • Ongoing preference for more natural products despite inflation
  • Herbal/traditional products remains a highly competitive area
PROSPECTS AND OPPORTUNITIES
  • Herbal/traditional sleep aids and dermatologicals set to be the two most dynamic categories
  • Price pressure could influence purchasing behaviour as consumers look for savings
  • Players could focus on offering new novelties to deliver short-term growth opportunities
CATEGORY DATA
  • Table 88 Sales of Herbal/Traditional Products by Category: Value 2018-2023
  • Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2018-2023
  • Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2019-2023
  • Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2020-2023
  • Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2023-2028
  • Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2023-2028
PAEDIATRIC CONSUMER HEALTH IN BELGIUMKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Mixed results for paediatric consumer health as life returns to relative normality in Belgium
  • The ongoing reluctance to self-medicate children and the rising issue of product shortages limits sales
  • Janssen-Cilag and Boots Healthcare fight for the lead in paediatric consumer health
PROSPECTS AND OPPORTUNITIES
  • Although not a priority for manufacturers, paediatric consumer health likely to be further affected by supply shortages
  • Natural products likely to find favour among health conscious parents and guardians
  • Negative perceptions could harm sales of paediatric ibuprofen and aspirin but there remains promising potential for laxatives and cough, cold and allergy remedies
CATEGORY DATA
  • Table 94 Sales of Paediatric Consumer Health by Category: Value 2018-2023
  • Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023
  • Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2019-2023
  • Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2020-2023
  • Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2023-2028
  • Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2023-2028